VICTOR: Venetoclax or Intensive Chemotherapy for Treatment Of Favourable Risk Acute Myeloid Leukaemia: a molecularly guided study
Project: Research
Participants
- Lucinda Billingham (Researcher)
- Sylvie Freeman (Co-Investigator)
- Charles Craddock (Principal Investigator)
Colleges, School and Institutes
Short title | VICTOR: Venetoclax or Intensive Chemotherapy for Treatment Of Favourable Risk Acute Myeloid Leukaemia: a molecularly guided study |
---|---|
Status | Active |
Effective start/end date | 1/02/20 → 31/07/25 |